• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
  • Login
No Result
View All Result
Friday, June 2, 2023
Alternatives Watch
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
No Result
View All Result
Alternatives Watch
No Result
View All Result

Third Rock raises over $1bn for biotech potential

Susan BarretobySusan Barreto
June 16, 2022
in Manager News, Open Access, Private Equity
Third Rock raises over $1bn for biotech potential
ShareTweetShareSendSend

Third Rock Ventures closed the Third Rock Ventures Fund VI with $1.1 billion in commitments with the aim of building up biotech companies employing a hands-on approach with founders.

Fund VI is able to provide both initial Series A investment as well as follow-on capital to support companies throughout their lifecycle. Third Rock officials plan to allocate capital from Fund VI to invest in groundbreaking new companies from in the broader biotech ecosystem that are strongly aligned with Third Rock’s mission and strategy. The Boston-based firm will invest in approximately 10 biotech companies in the new fund.

“An important differentiator for Third Rock is the strength and maturity of our ideation ecosystem,” said Reid Huber, partner at Third Rock. “Our discovery pipeline is as robust as it has ever been, and with our established and proven model for integrating deep scientific and medical expertise with operational and business acumen, we are uniquely positioned to advance these innovations to patients.”

In addition to Huber, partners of Fund VI are Abbie Celniker, Neil Exter, Kevin Gillis, David Kaufman, M.D., Cary Pfeffer, M.D., Robert Tepper, M.D., and Jeffrey Tong. Third Rock also promoted Dodzie Sogah to venture partner. Dr. Sogah came to the firm in 2021 as an entrepreneur-in-residence, and now joins a team of business and scientific leaders in the venture partner role.

The $3.8 billion firm has invested in 60 companies. Importantly, companies across the portfolio have brought 18 products to the market across multiple therapeutic modalities and a broad range of disease indications including cancer, cardiovascular disease, depression, sickle cell disease, and rare genetic diseases among others.

“Over the course of our 15-year history, our focus on creating companies aimed at improving the lives of patients has not wavered,” said Gillis, partner and chief operating officer at Third Rock. “We have built a leading investor base that is supportive of our differentiated model that is hands on, team oriented, value creation driven, and built for the long term. We appreciate the strong support from existing limited partners and welcome our new investors.”

Tags: Life Sciences
ShareTweetShareSendSend
Previous Post

Two Sigma’s Venn names CEO

Next Post

MidOcean adds seasoned execs to private equity team

Related Posts

Mass PRIM adds $640m to diverse PE strategies
Pensions

Mass PRIM adds $640m to diverse PE strategies

Adams Street sees strong secondaries demand with $3.2bn fund close
Private Equity

Adams Street sees strong secondaries demand with $3.2bn fund close

IMRF approves $315m in new commitments
Pensions

IMRF approves $315m in new commitments

Ohio pension adds PE, credit funds
Pensions

Ohio pension adds PE, credit funds

Rhode Island adds to private assets
Consultants

Rhode Island adds to private assets

Next Post
MidOcean adds seasoned execs to private equity team

MidOcean adds seasoned execs to private equity team

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Activist investor Jana Partners escalates Freshpet battle with court filing

Activist investor Jana Partners escalates Freshpet battle with court filing

Rockhampton shuts pan-Asia fund

Rockhampton shuts pan-Asia fund

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

AW Top 10 reads for May 2023

AW Top 10 reads for May

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo